Congressional investigators are wid...

Congressional investigators are widening their probe of potential conflicts of interest between federal rule employees and pharmaceutical and biotechnology companies. Allegations of questionable payments and snug relationships first surfaced late last year; lately they have expanded from the National Institutes of Health (NIH) to include personnel at the diet and Drug Administration (FDA), too. the pair agencies are tightening their governments governing outside consulting arrangements and are seeking more information onward the extent of such activity, as additional federal watchdog